EUVIMEDEUVIMED entdecken
Klinische StudieKontrollierte klinische Studie

Potency Assessment of Topical Corticoids in the Vasoconstrictor Assay and on Tuberculin-Induced Inflammation

W Schalla, S Schorning

Skin Pharmacology · 2009

DOI: 10.1159/000210949 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Skin Pharmacology, 2009. Verfasst von W Schalla und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cutaneous Studies International (CSI), Freiburg, FRG. Hauptthemen laut MEDLINE: Tuberculin Test. Die Arbeit wurde bisher 6-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The topical anti-inflammatory activity of potent and very potent corticoids was studied in normal and inflamed skin using the vasoconstriction assay and tuberculin-induced inflammation in four double-blind intraindividual comparison trials. Instrumental techniques in addition to visual scores and several time points were applied to get better insight into the reliability of the models and the sensitivity of the different variables. Beta-methasone-17-valerate and two concentrations of prednicarbate were used as potent corticoids, clobetasol-17-propionate, betamethasone-17,21-dipropionate and different biopharmaceutical forms of desoximetasone (DOM) as very potent corticoids. Visual scores, the reactive skin hyperemia after arterial occlusion and skin colorimetry were used to quantify vasoconstriction; erythema scores, surface area of infiltration and changes in skin colorimetry, skin blood flow and skin temperature for the tuberculin reaction. The time courses of blanching (n = 20) and of the tuberculin reaction (n = 10) were described by orthogonal polynomials and the coefficients were statistically analyzed by nonparametric tests, the discriminative variables in tuberculin inflammation in addition by the parametric multiple analysis of variance. Important differences in the release rates of corticoids demand several assessment times and not just one as often used. The potency ranking may otherwise be misleading. In general, ointments released corticoids slowlier than the cream which in turn liberated slowlier than the gels. The DOM gel declined rapidly after an apparent peak at 5.5 h in terms of its blanching effect, but was nevertheless comparable after once-daily application to other very potent corticoids in its activity against delayed-type inflammation. Such differences may explain discrepancies found for some corticoid preparations between their

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberculin TestAdministration, TopicalAdultAnti-Inflammatory AgentsColorDouble-Blind MethodGlucocorticoidsHumansHyperemiaPharmaceutical VehiclesRegional Blood FlowSkinSkin TemperatureVasoconstriction

Substanzen

Anti-Inflammatory AgentsGlucocorticoidsPharmaceutical Vehicles

Autor:innen und Institutionen

  • Cutaneous Studies International (CSI), Freiburg, FRG.

Zitieren

APA

Schalla, W., & Schorning, S. (2009). Potency Assessment of Topical Corticoids in the Vasoconstrictor Assay and on Tuberculin-Induced Inflammation. Skin Pharmacology. https://doi.org/10.1159/000210949

Vancouver

Schalla W, Schorning S. Potency Assessment of Topical Corticoids in the Vasoconstrictor Assay and on Tuberculin-Induced Inflammation. Skin Pharmacology. 2009. doi:10.1159/000210949

BibTeX
@article{Schalla2009,
  author = {Schalla, W and Schorning, S},
  title = {Potency Assessment of Topical Corticoids in the Vasoconstrictor Assay and on Tuberculin-Induced Inflammation},
  journal = {Skin Pharmacology},
  year = {2009},
  doi = {10.1159/000210949}
}
Kostenlos starten →